NOVIRX Trademark

Trademark Overview

On Friday, September 4, 2020, a trademark application was filed for NOVIRX with the United States Patent and Trademark Office. The USPTO has given the NOVIRX trademark a serial number of 90160639. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 4, 2023. This trademark is owned by Global Therapeutics & Innovation, Ltd. The NOVIRX trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
novirx

General Information

Serial Number90160639
Word MarkNOVIRX
Filing DateFriday, September 4, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements

Goods and ServicesDrug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 9, 2020
Primary Code005
First Use Anywhere DateWednesday, November 23, 2022
First Use In Commerce DateWednesday, November 23, 2022

Trademark Owner History

Party NameGlobal Therapeutics & Innovation, Ltd
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89104
Party NameGlobal Therapeutics & Innovation, Ltd
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89104

Trademark Events

Event DateEvent Description
Tuesday, April 4, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, April 4, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, April 4, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, December 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 19, 2022NON-FINAL ACTION E-MAILED
Monday, December 19, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, December 14, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, November 28, 2022USE AMENDMENT FILED
Monday, December 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 28, 2022TEAS STATEMENT OF USE RECEIVED
Friday, August 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 17, 2022SOU EXTENSION 3 GRANTED
Wednesday, August 17, 2022SOU EXTENSION 3 FILED
Wednesday, August 17, 2022TEAS EXTENSION RECEIVED
Wednesday, March 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 7, 2022SOU EXTENSION 2 GRANTED
Monday, March 7, 2022SOU EXTENSION 2 FILED
Monday, March 7, 2022TEAS EXTENSION RECEIVED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021SOU EXTENSION 1 GRANTED
Monday, August 23, 2021SOU EXTENSION 1 FILED
Monday, August 23, 2021TEAS EXTENSION RECEIVED
Tuesday, April 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 12, 2021ASSIGNED TO EXAMINER
Friday, October 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 8, 2020NEW APPLICATION ENTERED

Related Keywords

novirx ingredients active wide variety pharmaceuticals release controlled agents delivery drug